Chief Development Officer
Omer Siddiqui serves as our Chief Development Officer. Prior to joining Vanqua, Omer was overseeing the development operations and project management at Harpoon Therapeutics to progress clinical programs in the clinic. Previously, Omer was a member of the early leadership team at Alector, a biotech company working on leveraging the immune system to discover cures for neurodegenerative diseases. At Alector, he served as head of clinical development operations and led the strategy and execution of trials for the portfolio of drugs in the clinic across multiple neurological indications. He has successfully built high-performing cross functional teams to oversee clinical programs in various organizations. Previous career experience includes leadership roles at Allakos, a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, and at Genentech research and early development. Omer received an MSc in Biotechnology at Johns Hopkins University and a BSc in Biology from the University of Western Ontario, Canada.